GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutati

Quindós Varela, María

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/3625

ISSN: 0959-8049

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

EUROPEAN JOURNAL OF CANCER

Type of content

Artigo